Introduction There is a high prevalence of cardiovascular disease (CVD) among patients with cancer.1 The incidence of cardiovascular (CV) events, such as myocardial infarction (MI) and ischemic stroke, is higher in patients with cancer than it is in those without cancer.2 As clinical outcomes for people diagnosed with cancer have improved considerably over the past 2 decades, the competing risks from CV comorbidity and mortality have gained increasing relevance.3 Therapies such as immune...